Log in to search using one of your social media accounts:

 

Rheumatoid Arthritis Linked with COPD Hospitalization
The risk is nearly twice as high as in the general population, and women are at significantly higher risk. (Source: CancerNetwork)
Source: CancerNetwork - November 21, 2017 Category: Cancer & Oncology Authors: Gregory M. Weiss, M.D. Tags: COPD Rheumatoid Arthritis Source Type: news

Rheumatoid Arthritis Linked with COPD Hospitalization
The risk is nearly twice as high as in the general population, and women are at significantly higher risk. (Source: ConsultantLive)
Source: ConsultantLive - November 21, 2017 Category: Internal Medicine Authors: Gregory M. Weiss, M.D. Tags: COPD Rheumatoid Arthritis Source Type: news

Ted Koppel and wife Grace Anne on living with COPD
Chronic Obstructive Pulmonary Disease is the third leading cause of death in U.S., yet it is little understood by millions who have gone undiagnosed (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 20, 2017 Category: Consumer Health News Source Type: news

Ted and Grace Anne Koppel on COPD, third leading cause of death in U.S.
Chronic obstructive pulmonary disease, or COPD, is the nation's third biggest killer after heart disease and cancer. About 150,000 Americans die of COPD each year. Among women, it is more deadly than breast and ovarian cancers combined. Ted Koppel focuses on the disease for a report next weekend on CBS "Sunday Morning." His wife, Grace Anne, was given only a few years to live when she was diagnosed 16 years ago. The Koppels join "CBS This Morning" to discuss why they're advocating for more research into prevention and treatment. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 20, 2017 Category: Consumer Health News Source Type: news

ResMed Elects Karen Drexler to its Board of Directors
A champion of women in leadership, Drexler brings wealth of experience at both commercial-stage and start-up medtech and healthcare companies Also at annual meeting of shareholders, long-serving Director Chris Roberts announced his retirement SAN DIE... Devices, Personnel ResMed, sleep apnea, chronic obstructive pulmonary disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2017 Category: Pharmaceuticals Source Type: news

Poor COPD care leading to unnecessary A & E admissions
Fifth of COPD patients visit A&E per year Related items fromOnMedica End-of-life care in COPD Antibody therapy reduces flare-ups in treatment-resistant COPD Making sense of the new LABAs and LAMAs for COPD Inhalers Rheumatoid arthritis may increase COPD risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 17, 2017 Category: UK Health Source Type: news

EU Approves Trelegy Ellipta for COPD EU Approves Trelegy Ellipta for COPD
The European Commission has granted marketing authorization for fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline PLC and Innoviva, Inc) for the treatment of COPD.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news

Propeller Health, Express Scripts ink smart inhaler sensor deal
Propeller Health said today it inked a strategic partnership deal with Express Scripts (NSDQ:ESRX) to provide Propeller’s digital solutions to Express Script members. Through the deal, St. Louis-based Express Script members will be able to use inhaler sensors and connected mobile applications to manage their asthma or chronic obstructive pulmonary disease. The companies touted it as the largest respiratory digital health deployment with a pharmacy manager to date. Read the whole story on our sister site, Drug Delivery Business The post Propeller Health, Express Scripts ink smart inhaler sensor deal app...
Source: Mass Device - November 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Drug-Device Combinations Patient Monitoring Respiratory Express Scripts Propeller Health Source Type: news

Health Tip: If There's a Wildfire Nearby
-- Smoke from a nearby wildfire threatens anyone, but poses even more of a threat to people with asthma, COPD, heart disease or diabetes, the American Lung Association says. The group suggests what to do if a wildfire burns near you: Stay inside,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2017 Category: General Medicine Source Type: news

Study: Process used to select lung transplant patients may need to be changed
(University of Maryland Medical Center) New research from the University of Maryland School of Medicine suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long a person might survive without a lung transplant and therefore, may mislead clinicians. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Theravance Biopharma and Mylan Submit NDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Nov. 13, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ( " Theravance Biopharma " ) and Mylan N.V. (NASDAQ, TASE: MYL) ( " Mylan " ) today announced the submission of a New Drug Application... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - November 13, 2017 Category: Drugs & Pharmacology Source Type: news

Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Filing Supported by Positive Results from Two Pivotal Phase 3 Efficacy Studies and One 12-Month Phase 3 Safety Study DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Nov. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Theravance Biopharma, Inc.... Biopharmaceuticals, FDA Theravance Biopharma, Mylan, Revefenacin, Chronic Obstructive Pulmonary Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2017 Category: Pharmaceuticals Source Type: news

Mepolizumab Reduces Exacerbations in Eosinophilic COPD Mepolizumab Reduces Exacerbations in Eosinophilic COPD
Mepolizumab reduced time to first moderate or severe exacerbation in patients with the eosinophilic phenotype of COPD.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight Funding available! The National Network of Libraries of Medicine, Middle Atlantic Region, is accepting applications for health information outreach, health literacy initiatives, emergency preparedness partnerships and health sciences library projects. Applications will be due by COB on December 1. See a recent blog post from Executive Director, Kate Flewelling for details, or review our funding opportunities and start your application today! Rural Health Week begins on Monday, November 13! Wondering how you can participate?...
Source: NN/LM Middle Atlantic Region Blog - November 10, 2017 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Health Tip: Understanding COPD
-- Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death in the United States, affecting some 16 million Americans and potentially millions more who don't know they have it. According to the National Heart, Blood, and Lung... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 10, 2017 Category: General Medicine Source Type: news

Health Tip: Understanding COPD
Title: Health Tip: Understanding COPDCategory: Health NewsCreated: 11/10/2017 12:00:00 AMLast Editorial Review: 11/10/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 10, 2017 Category: Respiratory Medicine Source Type: news

Announcement: National Chronic Obstructive Pulmonary Disease Awareness Month — November 2017
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 9, 2017 Category: American Health Source Type: news

Startup aims to disrupt asthma, COPD space with digital inhaler
Formed just two years ago, pharma startup Pneuma Respiratory is developing a digital inhaler that it touts as the first of its kind. The company is looking to bring its technology to the more than 40 million people who suffer from asthma or chronic obstructive pulmonary disease in the U.S. They’re stepping into a highly competitive market, largely dominated by companies like GlaxoSmithKline (NYSE:GSK) and Merck (NYSE:MRK). Get the full story at our sister site, Drug Delivery Business News. The post Startup aims to disrupt asthma, COPD space with digital inhaler appeared first on MassDevi...
Source: Mass Device - November 8, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations mHealth (Mobile Health) Pharma Pharmaceuticals Respiratory GlaxoSmithKline plc Merck Pfizer pneumarespiratory Source Type: news

RA Associated With Higher Risk of COPD Hospitalization
Risk is 47 percent higher in RA patients than general population after adjustment for confounders (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 2, 2017 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Pulmonology, Rheumatology, Journal, Source Type: news

Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Presentations Highlight 24-Hour Serial Spirometry Subgroup Findings from Two Replicate Pivotal Phase 3 Studies; Improvements Observed in St. George's Respiratory Questionnaire and COPD Assessment Test Results DUBLIN and HERTFORDSHIRE, England and PITTS... Biopharmaceuticals Theravance Biopharma, Mylan, Revefenacin, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2017 Category: Pharmaceuticals Source Type: news

Rheumatoid Arthritis Linked to Risk of COPD
Title: Rheumatoid Arthritis Linked to Risk of COPDCategory: Health NewsCreated: 10/31/2017 12:00:00 AMLast Editorial Review: 11/1/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - November 1, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis Linked to Risk of COPD
People with rheumatoid arthritis appear to have a higher risk of the lung condition chronic obstructive pulmonary disease (COPD), researchers report. (Source: WebMD Health)
Source: WebMD Health - October 31, 2017 Category: Consumer Health News Source Type: news

November 2017
Healthy Body, Happy Heart : Improve Your Heart Health When Food Consumes You : Taking Eating to Extremes Reducing Children ’s Chances of Asthma Out of Breath? Get Tested for COPD Healthy Bones, Joints, Muscles, and Skin (Source: NIH News in Health)
Source: NIH News in Health - October 31, 2017 Category: Consumer Health News Source Type: news

Humana to pilot Revon's self-triage app for COPD
Humana has tapped Crestwood, Kentucky-based Revon Systems for a market-wide pilot of the latter ’s mobile self-triage platform, the Revon Smart Symptom Tracker. The program aims to help a select population of Medicare Advantage members with chronic obstructive pulmonary disease (COPD) better assess day-to-day variations in their symptoms. (Source: mobihealthnews)
Source: mobihealthnews - October 31, 2017 Category: Information Technology Source Type: news

Rheumatoid Arthritis Linked to Risk of COPD
TUESDAY, Oct. 31, 2017 -- People with rheumatoid arthritis appear to have a higher risk of the lung condition chronic obstructive pulmonary disease (COPD), researchers report. The study found that people with rheumatoid arthritis were 47 percent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 31, 2017 Category: General Medicine Source Type: news

CHEST: Can Vagrancy Ward Off COPD? (CME/CE)
(MedPage Today) -- Even in vulnerable people, high exercise level protects lungs, study suggests (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - October 30, 2017 Category: Consumer Health News Source Type: news

E - Cigarettes Alter Defense Proteins in Airway Secretions
Levels of innate defense proteins associated with COPD found to be elevated in e - cigarette users (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 30, 2017 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Nursing, ENT, Pathology, Pediatrics, Pulmonology, Journal, Source Type: news

CHEST: Novel Agent Boosts Quality of Life in COPD (CME/CE)
(MedPage Today) -- Would be first once-daily LAMA delivered by nebulizer (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - October 30, 2017 Category: Allergy & Immunology Source Type: news

Louisville startup lends its technology to help Humana's Bold Goal
Humana Inc. and Revon Systems Inc., a Crestwood-based health technology startup, will team up to help a few Louisville seniors breathe a little easier as part of Humana's Bold Goal. The companies will launch a market-wide pilot program for select local seniors on Humana's Medicare Advantage plans who have been diagnosed with chronic obstructive pulmonary disease. COPD is chronic lung condition that is the result of damage to lungs. Revon develops software and devices that h elp people and care… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 30, 2017 Category: American Health Authors: Chris Larson Source Type: news

Clinical Pearls for Treating COPD
Exacerbations of chronic obstructive pulmonary disease (COPD) in the elderly and in the post-acute and long-term care populations “tend to present very atypically,” with symptoms such as dizziness, weakness, chest pain, and confusion, Milta Little, DO, CMD, said at the Annual Conference of AMDA — the Society for Post-Acute and Long-Term Care Medicine. (Source: Caring for the Ages)
Source: Caring for the Ages - October 28, 2017 Category: Health Management Authors: Christine Kilgore Source Type: news

COPD symptoms: Could YOU spot THESE four signs of DEADLY lung disease?
COPD is a lung disease often caused by smoking. Here are four key symptoms of the deadly condition. (Source: Daily Express - Health)
Source: Daily Express - Health - October 27, 2017 Category: Consumer Health News Source Type: news

Clinical Wearables: Navigating the Next Health Technology Boom
Wearables have undoubtedly made their mark in the health and wellness industry. With the market slated to double in size by 2021 as vendors plan to ship a total of 125.5 million wearable devices this year, according to the International Data Corporation, tracking your steps during your work day, your reps during your workouts and even analyzing your personal sleeping patterns has become the new normal. While consumer wearables have seen a monumental level of success across the board, clinical wearables have struggled to reach a similar level of notoriety until recently. However, in the past several years we have seen ...
Source: MDDI - October 27, 2017 Category: Medical Devices Authors: Ravi Kuppuraj Tags: Digital Health Source Type: news

COPD: Better Sepsis Outcomes With Reduced Inflammation? COPD: Better Sepsis Outcomes With Reduced Inflammation?
According to a recent study, patients with COPD who present with sepsis may do better when medication addresses inflammation.Medscape Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Viewpoint Source Type: news

Blood-thinning drugs may reduce dementia risk in people with irregular heartbeats
Conclusion If you’ve been diagnosed with AF and you have been prescribed anticoagulant treatments such as warfarin or clopidogrel, we already know they protect you against having a stroke. This study suggests they may also help to protect you against dementia. Cutting the risk of dementia for people who have a raised risk because of AF would be an exciting step forward. Unfortunately, we can’t tell from this study whether the protection against dementia was down to the anticoagulants, because of the possible effect of unmeasured confounding factors. Usually, we would want to see a randomised controlled trial (R...
Source: NHS News Feed - October 25, 2017 Category: Consumer Health News Tags: Neurology Source Type: news

Literature review: the economic costs of lung disease and the cost effectiveness of policy and service interventions
Published evidence on the economic costs of lung disease (incl asthma, COPD, cystic fibrosis) and the cost-effectiveness of different NHS activities, programmes and campaigns to combat lung problems. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 24, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Rheumatoid arthritis may raise COPD risk
A new study of 50,000 people finds that those with rheumatoid arthritis had a 47 percent higher risk of COPD hospitalization than the general population. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 23, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Arthritis raises the risk of a deadly lung disease
The 400,000 people with rheumatoid arthritis in Britain and 50 million in the US are almost 50 per cent more likely to end up with COPD, researchers at the University of British Columbia found. (Source: the Mail online | Health)
Source: the Mail online | Health - October 20, 2017 Category: Consumer Health News Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight New funding available! The National Network of Libraries of Medicine, Middle Atlantic Region, is pleased to announce a new round of funding for health information outreach, health literacy initiatives, emergency preparedness partnerships and health sciences library projects. Applications will be due by COB on December 1. See a recent blog post from Executive Director, Kate Flewelling for details, or review our funding opportunities and start your application today! Apply Today! Health science librarians are invited to parti...
Source: NN/LM Middle Atlantic Region Blog - October 20, 2017 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Rheumatoid arthritis may increase COPD risk
New research demonstrates an association Related items fromOnMedica COPD led to 3.2m deaths in 2015 worldwide Certain occupations linked to increased risk of rheumatoid arthritis Rheumatoid arthritis Diagnosis of COPD needs to be improved Physical activity decreases risk of dying in COPD (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 20, 2017 Category: UK Health Source Type: news

In RA, COPD Admissions Rise (CME/CE)
(MedPage Today) -- Patients with rheumatoid arthritis had a 47% increased risk of hospitalization for COPD (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 19, 2017 Category: Respiratory Medicine Source Type: news

Rheumatoid Arthritis linked to an increased risk of COPD
(Wiley) New research suggests that rheumatoid arthritis may increase the risk of developing chronic obstructive pulmonary disease (COPD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news

Connected Metered Dose Inhalers
In this article, H&T Presspart's programme manager Benjamin Jung and US sales and business development director Dana Shears describe the role of connected devices in the treatment of asthma and COPD. They discuss the requirements for mass adoption an … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 18, 2017 Category: Pharmaceuticals Source Type: news

Lung disease treatment: THIS popular fruit is linked to cure for deadly COPD
LUNG disease type, chronic obstructive pulmonary disease , is on the rise, but grapes have been linked to a new cure. (Source: Daily Express - Health)
Source: Daily Express - Health - October 16, 2017 Category: Consumer Health News Source Type: news

Brothers Thrive After Lung Transplants at Duke
Treatment TermsPulmonary fibrosis and interstitial lung diseaseLung transplantPulmonary rehabilitation Author Karen Doss Bowman Overview U.S. Air Force veteran Michael Bonnette and his brother Robert, a volunteer firefighter, are used to saving the lives of others. After developing pulmonary fibrosis, they turned to Duke University Hospital for double lung transplants because of its short wait times and pulmonary rehab program. Now, a few years later, the brothers are back to their active lifestyles. Hero Image20170927.bonnettes.web_.01.jpg Preview Image Content Blocks Section Features Images/Media Text Content ...
Source: dukehealth.org: Duke Health News - October 16, 2017 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news

Ageing Asia: What Does the Future Hold?
Conclusion To effectively meet the meets of the growing elderly population over the next few decades, it is crucial that we understand what socio-economic, cultural and political factors will drive their healthcare decision making, especially where out-of-pocket payment will be required.  Market research, grounded in local knowledge and expertise, is a key means of achieving this understanding. Whether via patients directly (recognizing the technological or capability limitations that may exist in the elderly population), or their caregivers (noting that the family has traditionally played an important role in provid...
Source: EyeForPharma - October 16, 2017 Category: Pharmaceuticals Authors: Marc Yates Source Type: news

West Virginians say Opioid epidemic most important health issue in the state
(Research!America) The opioid epidemic is the most important health issue in West Virginia, above obesity, cancer, chronic obstructive pulmonary disease (COPD) and dental disease, according to a state-based public opinion survey commissioned by Research!America. A strong majority of West Virginians (84%) say prescription pain medication abuse and addiction is a major problem in their community, and more than two-thirds (71%) say they know someone who experienced pain so severe they sought prescription medicines to treat it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2017 Category: International Medicine & Public Health Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include predicting mortality in those with congestive heart failure, bystander CPR impact, best management of stable COPD, and NOACs and bleeding risk (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - October 14, 2017 Category: Allergy & Immunology Source Type: news

Boehringer Ingelheim, Anthem partner for largest real-world COPD trial
As part of a research collaboration launched in 2014, Boehringer Ingelheim and Anthem have partnered to study people with chronic obstructive pulmonary disease in real-world settings to assess how commonly-prescribed drugs may reduce the occurrence of COPD exacerbations. The team, which also includes Anthem’s outcomes research subsidiary HealthCore, plans to investigate whether adding an inhaled corticosteroid to a LAMA-LABA combination provides a meaningful benefit – a question under debate in the respiratory space. Get the full story at our sister site, Drug Delivery Business News. The post Boehring...
Source: Mass Device - October 12, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Anthem Inc. Boehringer Ingelheim Pharmaceuticals Source Type: news

Tiotropium for Mild to Moderate COPD Tiotropium for Mild to Moderate COPD
Is it time to consider using a daily long-acting bronchodilator like tiotropium for early-stage COPD?Medscape Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 12, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Viewpoint Source Type: news

A'Triple' for COPD? A'Triple' for COPD?
Is an inhaled once-daily triple therapy effective for advanced chronic obstructive pulmonary disease?Medscape Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 10, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Viewpoint Source Type: news